Can a natural supplement tweak your metabolism? new study tests OEA
NCT ID NCT06840080
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested whether a single dose of oleoylethanolamide (OEA), a natural fat-like molecule, can change certain metabolic signals in the body. Forty healthy adults aged 30 and older with a BMI between 25 and 35 took either a placebo or OEA with LipiSperse (a formulation to improve absorption). Researchers measured changes in blood markers related to appetite and blood sugar control over a short period.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oleoylethanolamide (OEA) with LipiSperse
- What this could lead to
- If results show OEA affects metabolic pathways, it could point toward a supplement that helps manage appetite or blood sugar.
- What could go wrong
- This was a small, short-term study in healthy volunteers, so findings may not apply to people with metabolic conditions. The effects were measured after a single dose, not long-term use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS - MALE AND FEMALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RDC Clinical
Brisbane, Queensland, 4006, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can paying attention to your body rewire your brain waves in 30 minutes?
- New lung imaging technique uses inhaled gas to see inside your lungs
- Does age change how your body handles fisetin? new study aims to find out.
- Quinoa cookie trial: a tasty way to fight obesity?
- New RNA drug ORN252 tested in humans for first time
- Scientists test drug binding in healthy lungs to guide future treatments